First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma (aMCC) in England from 2013-2022: Results of a nationwide observational cohort study

First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma (aMCC) in England from 2013-2022: Results of a nationwide observational cohort study C. Knott, S. Mahmoudpour, M. Kearney, E. Boutmy, P. Verpillat.  Annals of Oncology (2023) 34 (suppl_2): S651-S700. 10.1016/annonc/annonc1329 ESMO 2023; 2023, 20-24 Oct.

https://oncologypro.esmo.org/meeting-resources/esmo-congress/first-line-treatment-tx-patterns-and-overall-survival-os-of-patients-pts-with-advanced-merkel-cell-carcinoma-amcc-in-england-from-2013-2022